PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4882 (108th)

Controlled Substances Export Reform Act of 2004

referredUnited States· United States Congress· EN

Introduced

21 July 2004

Last action

4 August 2004 · Referred

Status

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Sponsors

Rep. Pitts, Joseph R. [R-PA-16], Sen. Brown, Sherrod [D-OH], Rep. Greenwood, James C. [R-PA-8], Anna Eshoo, Rep. Deal, Nathan [R-GA-9], Rep. Gerlach, Jim [R-PA-6], Rep. Weldon, Curt [R-PA-7], Rep. Cannon, Chris [R-UT-3], Rep. Matheson, Jim [D-UT-4], Rep. Houghton, Amo [R-NY-34], Rob Bishop, Rep. Cunningham, Randy (Duke) [R-CA-50], Rep. Ramstad, Jim [R-MN-3]

Subjects

Discovery layer

Source updated

18 August 2025

Summary

Controlled Substances Export Reform Act of 2004 - Amends the Controlled Substances Import and Export Act to authorize the Attorney General to allow any narcotic drug in schedule I, II, III, or IV or any non-narcotic controlled substance in schedule I or II (covered drug) to be exported from the United States to a country for subsequent export to another country if: (1) both the country to which the covered drug is exported from the United States (first country) and the country to which it is subsequently exported (second country) are parties to the Single Convention on Narcotic Drugs, 1961, and the Convention on Psychotropic Substances; (2) the first and second countries have each maintained an adequate system of drug import controls; (3) regarding the first country, the covered drug is consigned to a holder of such permits or licenses as required under that country's laws and a permit to import the drug has been issued; (4) regarding the second country, substantial evidence that the drug is to be consigned to a permit holder as required under that country's laws is furnished, a permit to import it is to be issued, there is an actual need for the drug, and it will not be re-exported; (5) within 30 days after export from the first country, the person who exported it from the United States certifies that re-export has occurred; and (6) the Attorney General has issued a permit to export the covered drug from the United States.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 21 July 2004

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 21 July 2004

    Introduced

    Sponsor introductory remarks on measure. (CR E1450)

    Source: IntroReferral

  3. 21 July 2004

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 21 July 2004

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 21 July 2004

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  6. 22 July 2004

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  7. 4 August 2004

    Referred

    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.